Physician profile
Jonathan J Abraham
NPI 1508314808
$18,073.29
in general payments reported to CMS, 2019-2025
30 companies · $7,684 in 2025
The $7,684 reported for 2025 was more than what 95% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $26.31 · 2021: $1,465 · 2022: $2,727 · 2023: $2,828 · 2024: $3,343 · 2025: $7,684.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $8,937 · Food and Beverage: $4,918.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $8,936.61 |
| Food and Beverage | $4,918.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $6,117.19 | 2022-2025 | |
| Evolution Surgical, INC | $4,925.79 | 2021-2025 | |
| Paragon 28, INC. | $1,576.22 | 2022-2024 | Hammertube Sterile Implant Kits, Portfolio, Bun-Yo-Matic |
| Arthrex, INC. | $1,449.07 | 2023-2025 | |
| Smith+Nephew, INC. | $913.79 | 2020-2025 | Collagenase Santyl, Pico, Renasys Go V2 Home |
| Bioventus LLC | $362.12 | 2021-2025 | Exogen Ultrasound Bone Healing System |
| Alafair Biosciences, INC. | $275.32 | 2024 | Versawrap |
| Stryker Corporation | $247.75 | 2023-2024 | Infinity, N/A, Augment Injectable |
| Orthofix Medical, INC. | $234.63 | 2022-2024 | Physio-Stim, Accelstim |
| Nevro Corp. | $203.40 | 2022-2023 | Senza |
| Kerecis Limited | $178.93 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Depuy Synthes Sales INC. | $163.97 | 2023-2025 | Motoband Cp, Motoband, Minibunion |
| Tactile Systems Technology INC | $161.93 | 2023-2024 | Entre Plus, Flexitouch Plus |
| Curonix LLC | $149.98 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Musculoskeletal Transplant Foundation INC. | $148.31 | 2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $132.05 | 2022 | |
| Organogenesis INC. | $124.39 | 2022 | |
| Amgen INC. | $121.83 | 2025 | Krystexxa |
| Medshape, INC. | $118.90 | 2023 | Dynanail Helix, Washer, 15 Mm |
| Melinta Therapeutics, LLC | $93.11 | 2022 | |
| Linvatec Corporation | $89.53 | 2023 | Colink Afx |
| Abbvie INC. | $66.32 | 2021-2023 | Dalvance |
| Integra Lifesciences Corporation | $44.60 | 2023-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $39.15 | 2022-2023 | Jublia |
| Kci USA, INC. | $32.91 | 2021-2022 | |
| Paratek Pharmaceuticals, INC. | $24.68 | 2025 | Nuzyra |
| Stimwave Technologies Incorporated | $22.31 | 2022 | |
| Horizon Therapeutics Plc | $19.87 | 2021 | |
| Merck Sharp & Dohme LLC | $17.86 | 2023 | Bridion |
| Alfasigma USA, INC. | $17.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Abraham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.